218 related articles for article (PubMed ID: 15358157)
1. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
2. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.
Klucken J; Shin Y; Hyman BT; McLean PJ
Biochem Biophys Res Commun; 2004 Dec; 325(1):367-73. PubMed ID: 15522241
[TBL] [Abstract][Full Text] [Related]
4. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
5. Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells.
Nishiyama N; Nori A; Malugin A; Kasuya Y; Kopecková P; Kopecek J
Cancer Res; 2003 Nov; 63(22):7876-82. PubMed ID: 14633716
[TBL] [Abstract][Full Text] [Related]
6. Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells.
Kim HR; Kang HS; Kim HD
IUBMB Life; 1999 Oct; 48(4):429-33. PubMed ID: 10632574
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.
Auluck PK; Meulener MC; Bonini NM
J Biol Chem; 2005 Jan; 280(4):2873-8. PubMed ID: 15556931
[TBL] [Abstract][Full Text] [Related]
8. Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70.
Yu F; Xu H; Zhuo M; Sun L; Dong A; Liu X
Biochem Biophys Res Commun; 2005 May; 331(1):278-84. PubMed ID: 15845390
[TBL] [Abstract][Full Text] [Related]
9. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
Demidenko ZN; Vivo C; Halicka HD; Li CJ; Bhalla K; Broude EV; Blagosklonny MV
Cell Death Differ; 2006 Sep; 13(9):1434-41. PubMed ID: 16311509
[TBL] [Abstract][Full Text] [Related]
11. Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells.
Kaarniranta K; Ryhänen T; Sironen RK; Suuronen T; Elo MA; Karjalainen HM; Lammi MJ; Teräsvirta M; Uusitalo H; Salminen A
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):126-31. PubMed ID: 15950770
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
Albani D; Peverelli E; Rametta R; Batelli S; Veschini L; Negro A; Forloni G
FASEB J; 2004 Nov; 18(14):1713-5. PubMed ID: 15345691
[TBL] [Abstract][Full Text] [Related]
13. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.
Hasegawa T; Matsuzaki M; Takeda A; Kikuchi A; Akita H; Perry G; Smith MA; Itoyama Y
Brain Res; 2004 Jul; 1013(1):51-9. PubMed ID: 15196967
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic effects of alpha-synuclein aggregation.
Lundvig D; Lindersson E; Jensen PH
Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
[TBL] [Abstract][Full Text] [Related]
15. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
16. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
Kong B; Chae Y; Lee K
Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
[TBL] [Abstract][Full Text] [Related]
17. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation.
Novoselova TV; Margulis BA; Novoselov SS; Sapozhnikov AM; van der Spuy J; Cheetham ME; Guzhova IV
J Neurochem; 2005 Aug; 94(3):597-606. PubMed ID: 15992387
[TBL] [Abstract][Full Text] [Related]
18. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.
Matsuzaki M; Hasegawa T; Takeda A; Kikuchi A; Furukawa K; Kato Y; Itoyama Y
Brain Res; 2004 Apr; 1004(1-2):83-90. PubMed ID: 15033422
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of hsp70-1/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C.
Shu CW; Cheng NL; Chang WM; Tseng TL; Lai YK
J Cell Biochem; 2005 Apr; 94(6):1199-209. PubMed ID: 15696546
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.
Zhou Y; Shie FS; Piccardo P; Montine TJ; Zhang J
Neuroscience; 2004; 128(2):281-91. PubMed ID: 15350641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
